Our progress in the fall gives us strong momentum for the spring semester, even as we continue to monitor the omicron variant of COVID-19. Early reports suggest that it may be more easily spread than previous variants but may not cause more serious illness, especially in people who are vaccinated and people who have received booster shots. Providing convenient, no-cost access to vaccination on campus will continue to be an important part of the university’s response.
We’ll be updating this page as more information becomes available. As always, we will continue to evaluate our plans and policies as new information and public health guidance emerges.
Spring Semester Testing
Fully vaccinated people
Based on emerging medical evidence and expert advice, the university plans to incorporate at-home rapid antigen tests into our campus testing strategy for fully vaccinated students and employees, at no cost to them. Antigen tests use a self-administered nasal swab and provide results within about 15 minutes, allowing people with COVID-19 to quickly isolate themselves and contain the spread of disease. These tests are now widely available over the counter and are increasingly being used in public health response in the U.S. and around the world.
People not yet fully vaccinated
Students and employees who were required to test during the fall semester will continue to be required to undergo PCR testing weekly on campus by making an appointment.
Beginning Jan. 3, campus testing will move to a single location, the University Club, 803 State St. (intersection of State Street Mall and East Campus Mall). Thanks to the high campus vaccination rate, we are able to serve everyone at one location. Testing will be available by appointment Monday through Thursday, 8:30 a.m. to 4 p.m., closed noon to 1 p.m. for lunch, and Friday, 8:30 a.m. to 12:30 p.m.
How Do I Video Series
How do I navigate situations with people who have different risk tolerance from me?
How do I begin to feel safe in public again?
How do I make the decision to get the COVID-19 vaccine?